How AI describes Congruence Therapeutics

Congruence Therapeutics is a drug discovery company that leverages protein dynamics, biophysics, machine learning, and computational chemistry to inform therapy design. It positions itself as moving beyond static traditional drug design toward predictive in silico models that correct disease pathogenesis with unprecedented speed and accuracy. Its Revenir Product Engine is a discovery platform that reveals proteins in their full dynamic conformational ensemble and derives biophysical properties from a single amino acid sequence to guide development.